Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibacterial effectiveness of thyme and chamomile extracts vs chlorhexidine on salivary Streptococcus mutans
IRCT20171020036896N4Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of thyme extract, chamomile extract and chlorhexidine in carious lesion (3 arms), sponsored by Kerman University of Medical Sciences. Primary endpoint: Change in salivary Streptococcus mutans levels. Started Dec 2017; status: completed.
02
Drugs
thyme extractchamomile extractchlorhexidine
03
Conditions
carious lesion
Beyond the preview
Go deeper on IRCT20171020036896N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171020036896N4.